United States · FDA National Drug Code directory
Xarelto
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50458-578_5294926b-7812-41da-a0e8-56f492198450
- Product NDC
- 50458-578
- Form
- TABLET, FILM COATED
- Composition / generic term
- rivaroxaban
- Labeler
- Janssen Pharmaceuticals, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20111104
- Source listing expiry
- 20271231
Source-listed ingredients
- RIVAROXABAN — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 TABLET, FILM COATED in 1 BOTTLE (50458-578-07) · 50458-578-07
- 10 BLISTER PACK in 1 CARTON (50458-578-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK (50458-578-01) · 50458-578-10
- 30 TABLET, FILM COATED in 1 BOTTLE (50458-578-30) · 50458-578-30
- 90 TABLET, FILM COATED in 1 BOTTLE (50458-578-90) · 50458-578-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →